AXIOS May 20, 2024
The Food and Drug Administration has cleared Neuralink to implant its brain chip in a second patient after the company reportedly outlined fixes to an electrode problem that limited the device’s functionality in the first human test subject.
Why it matters: It’s another step forward for brain-computer interface devices that companies hope will someday treat neurological disorders.
Driving the news: Neuralink, which is owned by Elon Musk, said it is seeking applications for another patient with quadriplegia to test if the device can allow a person to do tasks like control a phone and computer.
- It outlined fixes that included embedding some of the device’s wiring deeper into the brain, the Wall Street Journal reported, citing a document and...
Today's Sponsors
Today's Sponsor